GSK's Oncology R&D Head: GSK2857916 'Proves We're Still Here And Serious'

 
• By Sten Stovall
Myeloma
GSK's monoclonal ADC GSK2857916 wins FDA breakthrough status in multiple myeloma • Source: Shutterstock

More from Clinical Trials

More from R&D